NICOLE DAVIS-MARENCO: Open Payments
NPI 1114788767 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 94 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,130
Food & beverage: $2,030Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $347 |
| Janssen Biotech, Inc. | 12 | $266 |
| Lilly USA, LLC | 16 | $265 |
| Novartis Pharmaceuticals Corporation | 16 | $239 |
| Incyte Corporation | 7 | $233 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $212 |
| E.R. Squibb & Sons, L.L.C. | 6 | $188 |
| UCB, Inc. | 5 | $150 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
Products named: TREMFYA, OPZELURA, RINVOQ, COSENTYX, Sotyktu, Bimzelx, TALTZ, SKYRIZI.
Industry payments across CA — which companies pay providers there.
